Thieme Case Report

Issue 02 · April 2021

Recommend Journal

Issue
Industrieinformationen
1
Checkpoint-Inhibition – Avelumab beim Merkelzellkarzinom und Nierenzellkarzinom (in Kombination mit Axtinib) (Sponsor: Merck Healthcare Germany GmbH) FREE ACCESS

Full Text

PDF (2429 kb)
Most Read
Archive

Journal

Authors

Subscription

Journals
Book Series
Login
Help
Portal
Return to Classic Website

German English

Thieme E-Books & E-Journals is a service of Georg Thieme Verlag and Thieme Medical Publishers, Inc.
© Georg Thieme Verlag KG

All Rights reserved.

Imprint | Privacy policy statement

Your Current IP Address: 3.135.246.28